Sarepta Therapeutics Inc. Watch

from 8-K 158 pages Credit Agreement Dated as of February 13, 2025 Among Sarepta Therapeutics, Inc., as Borrower the Lenders Party Hereto Jpmorgan Chase Bank, N.A. as Administrative Agent, Jpmorgan Chase Bank, N.A., Barclays Bank PLC, Citizens Bank, N.A., Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc., and Royal Bank of Canada as Joint Lead Arrangers and Joint Bookrunners, Barclays Bank PLC, Citizens Bank, N.A., Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc., and Royal Bank of Canada as Co-Syndication Agents, and Fifth Third Bank, National Association and Ubs AG, Stamford Branch as Co-Documentation Agents

from 10-Q 10 pages First Amendment to Loan Agreement

from 10-K 42 pages Guaranty and Security Agreement Dated as of December 20, 2019 by Sarepta Therapeutics, Inc. (As Borrower), the Guarantors Party Hereto, and Each Other Grantor From Time to Time Party Hereto in Favor of Biopharma Credit PLC

from 10-K 125 pages Loan Agreement Dated as of December 13, 2019 Among Sarepta Therapeutics, Inc. (As Borrower), the Guarantors Party Hereto, Biopharma Credit PLC (As Collateral Agent and a Lender), and Biopharma Credit Investments V (Master) LP (As a Lender) Loan Agreement

from 8-K 11 pages First Amendment to Credit and Security Agreement

from 8-K 12 pages First Amendment to Amended and Restated Credit and Security Agreement

from 10-Q 97 pages Credit and Security Agreement

from 10-Q 87 pages Amended and Restated Credit and Security Agreement

from 10-Q 80 pages Credit and Security Agreement